Abstract

Signal transducer and activator of transcription 3 (STAT3) controls cell survival, growth, migration, and invasion. Here, we observed that STAT3 exerted anti-apoptotic effects in breast cancer cells. On the other hand, miR-17-5p induced apoptosis in breast cancer cells, and overexpression of miR-17-5p sensitized MCF-7 cells to paclitaxel-induced apoptosis via STAT3. Overexpression of STAT3 in MCF-7 cells decreased paclitaxel-induced apoptosis, but STAT3 knockout abolished the miR-17-5p-induced increases in apoptosis. Finally, miR-17-5p promoted apoptosis by increasing p53 expression, which was inhibited by STAT3. These results demonstrate a novel pathway via which miR-17-5p inhibits STAT3 and increases p53 expression to promote apoptosis in breast cancer cells.

Highlights

  • Signal transducer and activator of transcription 3 (STAT3) is an important transcription factor [1]

  • These results demonstrate a novel pathway via which miR-17-5p inhibits STAT3 and increases p53 expression to promote apoptosis in breast cancer cells

  • We investigated the role of miR-17-5p, which may repress the translation of the STAT3 oncogene, in the control of breast cancer cell apoptosis

Read more

Summary

Introduction

Signal transducer and activator of transcription 3 (STAT3) is an important transcription factor [1]. Several studies have demonstrated that miRNAs play important roles in human cancer [6,7,8,9,10], and miR-17-5p is important in breast cancer. The miR-17-5p cluster acts as a tumor suppressor by directly inhibiting the expression of AIB1 and cyclin D1 in human breast cancer [11, 12]. Yu et al demonstrated that the miR17-5p cluster mediates migration and invasion in breast cancer cells by affecting the secretion of a heterotypic signal [13]. We investigated the role of miR-17-5p, which may repress the translation of the STAT3 oncogene, in the control of breast cancer cell apoptosis

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.